2D QSAR studies of several potent aminopyridine, anilinopyrimidine and pyridine carboxamide-based JNK inhibitors

Indian Journal of Pharmaceutical Sciences

Volumn 73, Issue 2, 2011, Pages 165-170

  Sharma, S ^a   Bagchi, B ^a   Mukhopadhyay, S ^b   Bothra, A K ^a  

^a RAIGANJ UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

Amino pyridine; JNK inhibitors; pyridine carboxamide; QSAR; regression analysis

Indexed keywords

AMINOPYRIDINE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY;

EID: 84863405457     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.91584     Document Type: Article

References (17)

1. David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and independent mechanism. J Cell Sci 2002;115:4317-25. (Pubitemid 35460702)
2. Schaeffer HJ, Weber MJ. Mitogen Activated protein kinase: Specific message from ubiquitous messengers. Mol Cell Biol 1999;19: 2435-44. (Pubitemid 29144487)
3. Liu M, Wang S, Clampit JE, Gum RJ, Haasch DL, Rondinone CM, et al. Discovery of a new class of 4-anilinopyrimidines as potent c-Jan N-terminal kinase inhibitors: Synthesis and SAR studies. Bioorg Med Chem Lett 2007;17:668-72. (Pubitemid 46108565)
4. Szczepankiewicz BG, Kosogof C, Nelson LT, Liu G, Liu B, Zhao H, et al. Aminopyridin-based c-Jan N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. J Med Chem 2006;49: 3563-80. (Pubitemid 43902462)
5. Zhao H, Serby MD, Xin Z, Szczepankiewicz BG, Liu M, Kosogof C, et al. Discovery of potent, highly selective and orally bio available pyridine carboxamide c-Jan NH2 terminal kinase inhibitors. J Med Chem 2006;49:4455-8. (Pubitemid 44162671)
6. Sharma P, Ghoshal N. Exploration of a binding mode benzothiazol- 2-yl acetonitrile pyrimidine core based derivatives as potent c-Jun N-terminal kinase-3 inhibitors and 3D-QSAR analyses. J Chem Inf Model 2006;46:1763-74. (Pubitemid 44185701)
7. Yi P, Qiu M. 3D-QSAR and docking studies of aminopyridine carboxamide inhibitors of c-Jun N-terminal kinase-1. Eur J Med Chem 2008;43:604-13. (Pubitemid 351323991)
8. Chen X, Liu M, Gilson MK. Binding DB: A Web-accessible molecular recognition database. Comb Chem High Throughput Screen 2002;4: 719-25.
9. Chen X, Lin Y, Liu M, Gilson MK. The binding database: Data management and interface design. Bioinformatics 2002;18:130-9. (Pubitemid 34145041)
10. Chen X, Lin Y, Gilson MK. The binding database: Overview and user's guide Biopolymers 2002;61:127-41.
11. Wiener H. Structural determination of paraffin boiling points. J Am Chem Soc 1947;69:17-20.
12. Randiac M. On the characterization of Molecular branching. J Am Chem Soc 1975;97:6609.
13. Kier LB, Hall LH. Molecular connectivity in structure-activity analysis, Letchworth, Hertfordshire; UK: Research Studies Press; 1986.
14. Eroglu E. Some QSAR Studies for a group of sulfonamide schiff base as carbonic Anhydrase CA 2 inhibitors. Int J Mol Sci 2008;9:181-97. (Pubitemid 351354606)
15. Kier LB. Use of molecular negentropy to encode structure governing biological-activity. J Pharm Sci 1980;69:807-10. (Pubitemid 11237864)
16. Basak SC, Harriss DK, Magnuson VR. Comparative study of lipophilicity vessus topological molecular descriptors in biological correlation. J Pharm Sci 1984;73:429-37. (Pubitemid 14134312)
17. Schmidt MW, Baldridge KK, Boatz JA, Elbert ST, Gordon MS, Jensen JH, et al. GAMESS Version= 24 Mar 2007 (R1) from Iowa State University. J Comput Chem 1993;14:1347-63.